Armistice Capital’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.8M | Sell |
1,629,600
-3,370,400
| -67% | -$28.5M | 0.24% | 50 |
|
|
2025
Q1 | $40.2M | Sell |
5,000,000
-1,400,000
| -22% | -$11.3M | 0.6% | 34 |
|
|
2024
Q4 | $57.5M | Sell |
6,400,000
-1,800,000
| -22% | -$16.2M | 0.78% | 25 |
|
|
2024
Q3 | $60.1M | Sell |
8,200,000
-2,936,000
| -26% | -$21.5M | 0.96% | 14 |
|
|
2024
Q2 | $63.6M | Sell |
11,136,000
-1,124,000
| -9% | -$6.42M | 0.8% | 13 |
|
|
2024
Q1 | $61.4M | Buy |
12,260,000
+2,724,000
| +29% | +$13.6M | 0.81% | 11 |
|
|
2023
Q4 | $85.7M | Buy |
9,536,000
+3,488,000
| +58% | +$31.4M | 1.17% | 5 |
|
|
2023
Q3 | $47M | Buy |
6,048,000
+1,356,000
| +29% | +$10.5M | 0.72% | 23 |
|
|
2023
Q2 | $45.4M | Buy |
4,692,000
+520,000
| +12% | +$5.03M | 0.66% | 25 |
|
|
2023
Q1 | $45.7M | Sell |
4,172,000
-828,000
| -17% | -$9.07M | 0.66% | 32 |
|
|
2022
Q4 | $21.6M | Buy |
5,000,000
+4,276,000
| +591% | +$18.5M | 0.38% | 47 |
|
|
2022
Q3 | $5.44M | Buy |
+724,000
| New | +$5.44M | 0.09% | 90 |
|
|
2020
Q4 | – | Sell |
-500,000
| Closed | -$7.37M | – | 106 |
|
|
2020
Q3 | $7.37M | Buy |
+500,000
| New | +$7.37M | 0.27% | 64 |
|